Hedge Funds to Watch for Facebook Fallout: D.E. Shaw, Appaloosa (Bloomberg)
Several prominent hedge funds could be among investors feeling the pain from Facebook Inc.’s recent plunge amid the Cambridge Analytica data crisis. AQR Capital Management, Appaloosa Management, Coatue Management and D.E. Shaw & Co. were the stock’s top hedge fund holders as of Dec. 31, with a combined 21.9 million shares, data compiled by Bloomberg show. While they’re not obliged to provide a public update on those holdings until May and could have adjusted positions during the first quarter, holdings that remained unchanged may have suffered.
Bill Ackman Finds Honest-To-God Finance People Still Willing To Associate With Bill Ackman (DealBreaker)
It’s awfully lonely being Bill Ackman. There’s just something about the guy that brings out the bully in, well, everybody. And he’s certainly given them plenty of ammunition while also watching his marriage of 25 years disintegrate. It’s enough to make a guy want to drown himself in queso and even generate a personal insight or two. Still, Bill Ackman is who he is, and can’t seem to change that to any great extent, which means that associating with him in any way brings all sorts of risks, from the financial to the reputational. But at least two people of character are willing to stand by this beaten-down soul, two people with actual résumés, even, albeit two people who are more-or-less retired.
Alex Oakenman / shutterstock.com
The Billionaire Whisperer Who United Bezos, Buffett and Dimon (Bloomberg)
Todd Combs spends most of his days reading in a quiet office in Omaha, where he’s an investment manager at Berkshire Hathaway Inc. But one day last year he found himself on a flight to Seattle with an unusual mission: Pitch Jeff Bezos on a bold idea for wringing costs out of the U.S. health-care system. Two of the biggest corporate chieftains in America-his boss, Warren Buffett, and Jamie Dimon, who runs the largest bank in the country-had already signed on. But they wanted the Amazon.com Inc. chief executive officer on board as well.
Balyasny Hedge Fund Firm Loses About 10 Macro Traders (Bloomberg)
Dmitry Balyasny’s hedge fund firm saw about 10 macro traders leave last week as two of its main multistrategy funds lost money this year and it moved to reduce costs. Some employees were cut from Balyasny Asset Management’s Anthem training program, including its head, Mitesh Parikh, said people with knowledge of the matter. Anthem was started in 2016 for younger managers, who were given small pools of capital to invest, and has made money since inception, the people said.
Insider Buying: Arcus Biosciences Inc (RCUS) CEO Purchases 66,666 Shares of Stock (RegistrarJournal.com)
Arcus Biosciences Inc (NYSE:RCUS) CEO Terry J. Rosen acquired 66,666 shares of Arcus Biosciences stock in a transaction dated Monday, March 19th. The stock was purchased at an average cost of $15.00 per share, for a total transaction of $999,990.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.
Insider Buying: SCYNEXIS Inc (NASDAQ:SCYX) CEO Acquires 100,000 Shares of Stock (StockNewsTimes.com)
SCYNEXIS Inc (NASDAQ:SCYX) CEO Marco Taglietti purchased 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 8th. The shares were bought at an average cost of $1.69 per share, for a total transaction of $169,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 404,000 shares in the company, valued at approximately $682,760. The transaction was disclosed in a document filed with the SEC.
Insider Buying: RealNetworks Inc (RNWK) CFO Buys 35,816 Shares of Stock (LedgerGazette.com)
RealNetworks Inc (NASDAQ:RNWK) CFO Cary Baker acquired 35,816 shares of the stock in a transaction dated Thursday, March 1st. The shares were purchased at an average price of $2.93 per share, for a total transaction of $104,940.88. Following the completion of the transaction, the chief financial officer now owns 18,266 shares of the company’s stock, valued at approximately $53,519.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Insider Buying: Appian Corp (NASDAQ:APPN) Major Shareholder Buys $712,525.00 in Stock (StockNewsTimes.com)
Appian Corp (NASDAQ:APPN) major shareholder Abdiel Capital Management, Llc acquired 27,500 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The stock was acquired at an average price of $25.91 per share, for a total transaction of $712,525.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.
Insider Selling: Heron Therapeutics Inc (HRTX) VP Sells 18,000 Shares of Stock (LedgerGazette.com)
Heron Therapeutics Inc (NASDAQ:HRTX) VP Kimberly Manhard sold 18,000 shares of Heron Therapeutics stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $30.00, for a total value of $540,000.00. Following the sale, the vice president now directly owns 18,000 shares of the company’s stock, valued at $540,000. The transaction was disclosed in a document filed with the SEC.
Insider Buying: Stellus Capital Investment Corp (NYSE:SCM) Insider Buys 10,000 Shares of Stock (RegistrarJournal.com)
Stellus Capital Investment Corp (NYSE:SCM) insider Robert T. Ladd acquired 10,000 shares of the company’s stock in a transaction dated Friday, March 16th. The shares were acquired at an average price of $11.68 per share, for a total transaction of $116,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission.
